| Literature DB >> 25945114 |
Yau Lam1, Tzi Bun Ng2, Ren Ming Yao1, Jun Shi1, Kai Xu1, Stephen Cho Wing Sze1, Kalin Yanbo Zhang1.
Abstract
Dendrobium species, commonly known as "Shihu" or "Huangcao," represents the second largest genus of Orchidaceae, which are used commonly as tonic herbs and healthy food in many Asian countries. The aim of this paper is to review the history, chemistry, and pharmacology of different Dendrobium species on the basis of the latest academic literatures found in Google Scholar, PubMed, Sciencedirect, Scopus, and SID.Entities:
Year: 2015 PMID: 25945114 PMCID: PMC4402476 DOI: 10.1155/2015/841752
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
The compounds of various Dendrobium species.
| Species | Constituent | Chemical formula | Structures of compound | Reference |
|---|---|---|---|---|
|
| ||||
| Bibenzyls derivatives | ||||
| Amoenylin | R1 = R3 = Me, R2 = OH, R4 = H, R5 = OMe |
|
[ | |
| Isoamoenylin | R1 = R3 = Me, R2 = OMe, R4 = OH, R5 = H | |||
| Moscatilin (analogues) | — | |||
| 3,4′-Dihydroxy-5-methoxybibenzyl | — | |||
| — | R1 = R2 = R4 = H, R3 = Me, R5 = OH | |||
| — | R1 = R3 = Me, R2 = OH, R4 = H, R5 = OMe | |||
| — | R1 = R3 = Me, R2 = OAc, R4 = H, R5 = OMe | |||
| — | R1 = R3 = Me, R2 = OMe, R4 = OAc, R5 = H | |||
| — | R1 = Ac, R2 = R4 = H, R3 = Me, R5 = OAc | |||
| — | R1 = R3 = Me, R2 = R5 = OH, R4 = OMe | |||
| — | R1 = R3 = Me, R2 = R4 = OMe, R5 = OH | |||
| — | R1 = R3 = Me, R2 = R5 = OMe, R4 = OAc | |||
| — | R1 = R2 = R5 = H, R3 = Me, R4 = OH | |||
| — | R1 = Ac, R2 = R5 = H, R3 = Me, R4 = OAc | |||
| — | R1 = R2 = R3 = R4 = H, R5 = OH | |||
|
| ||||
|
| ||||
| Bibenzyls derivatives | ||||
| Dendrocandin C | R1 = R2 = R5 = OH, R3 = R6 = OCH3, |
| [ | |
| Amotin (type 1, sesquiterpenoids) | — |
| [ | |
| Amoenin (type 2 sesquiterpenoids) | — |
| [ | |
| Flaccidin (9,10-dihydrophenanthropyran) | — |
| [ | |
| Bibenzyls derivatives | ||||
| 4,4-Dihydroxy-3,5-dimethoxybibenzyl | R2 = R5 = OH, R1 = R3 = OCH3, R4 = R6 = OH |
| [ | |
| Dendrocandin B | — |
| [ | |
|
| ||||
|
| ||||
| Aromatic compounds | ||||
| Flavanthrin | — |
| [ | |
| Coelonin | R1 = OH, R2 = OMe |
| [ | |
| Moscatin | — |
| [ | |
| Gigantol | R1 = R3 = OMe, R2 = OH |
| [ | |
| Dibutyl phthalate | R = CH2CH2CH2CH3
|
| [ | |
|
| — |
| [ | |
|
| ||||
|
| ||||
| Phenanthrenequinone | ||||
| Dendronone (5-hydroxy-7-methoxy-9,10-dihydro-1,4-phenanthrenequinone) | — |
| [ | |
|
| ||||
|
| ||||
| Aromatic organic compounds | ||||
| (Fluorenones) | ||||
| Dendroflorin | R1 = H, R2 = OH |
| [ | |
| 1,4,5-trihydroxy-7-methoxy-9H-fluoren-9-one | — |
| [ | |
| (Fluorenol) | ||||
| (9R)-4methoxy-9H-fluorene-2,5,9-triol | R = H |
| [ | |
| Phenanthrene | ||||
| 2,7-dihydroxy-8methoxyphenanthro[4,5-bcd]pyran-5(5H)-one | — |
| [ | |
|
| ||||
|
| ||||
| Bibenzyl | ||||
| Densiflorol A | — |
| [ | |
| Phenanthrenedione | ||||
| Densiflorol B | R = H |
| [ | |
| Dendroflorin | R = OH |
| [ | |
| Known as oleanolic acid and b-sitosterol compounds | ||||
| (A) Dengibsin | R = H |
| [ | |
| (B) Cypripedin | R = OMe |
| [ | |
| (C) Gigantol | R = OH, R = H, R = OMe |
| [ | |
| (F) Naringenin | R = H |
| [ | |
| (H) Moscatin | — |
| [ | |
| (I) 2,6-dihydroxy-1,5,7-trimethoxyphenanthrene | — |
| [ | |
| (J) 4,7-dihydroxy-2-methoxy-9,10-dihydrophenanthrene | — |
| [ | |
| (K) Scoparone | R = R = OMe |
| [ | |
|
| ||||
|
| ||||
| Monoaromatic | ||||
| compounds | ||||
| Bis(2-ethylhexyl)phthalate | CH2CH(C2H5)(CH2)3CH3
|
| [ | |
| Ethyl haematommate | C11H12O5 |
| [ | |
| Methyl | C10H12O4 |
| [ | |
|
| R = COOCH2(CH2)20CH3
|
| [ | |
|
| ||||
|
| ||||
| Sesquiterpenes | ||||
| (Dendronobilins A) | ||||
| Copacamphane-type | (1R,2R,4S,5S,6S,8S,9R)-2,8-Dihydroxycopacamphan-15-one |
| [ | |
| Picrotoxane-type | (2b,3b,4b,5b)-2,4,11-Trihydroxy-picrotoxano-3(15)-lactone |
| [ | |
| Picrotoxane-type | (2b,3b,5b,9a,11b)-2,11-Epoxy-9,11,13-trihydroxypicrotoxano3(15)-lactone |
| [ | |
| Picrotoxane-type | (2b,3b,5b,12R*)-2,11,13-Trihydroxy-picrotoxano-3(15)-lactone |
| [ | |
| Picrotoxane-type | (2b,3b,5b,12S*)2,11,13-Trihydroxy-picrotoxano-3(15)-lactone |
| [ | |
| Picrotoxane-type | (2b,3b,5b,9a)-,10-Cyclo-2,11,13-trihydroxy-picrotoxano-3(15)-lactone |
| [ | |
| Muurolene-type | (9b,10a)-Muurol-4-ene-9,10,11-triol |
| [ | |
| Alloaromadendrene-type | (10a)-Alloaromadendrene-10,12,14-triol |
| [ | |
| Cyclocopacamphane-type | (5b)-Cyclocopacamphane-5,12,15-triol |
| [ | |
| Bibenzyl derivatives | ||||
| Dendronophenol A | 2,2′,9,9′-Tetramethoxy13′,14′-peroxy-1,1′-bis(bibenzyl)-6,6′-diol) |
| [ | |
| Dendronophenol B | 1-(2′,6′-Dimethoxy7′,8′-peroxyphenyl-propyl)-2,9-dimethoxybibenzyl-6,9′-diol) |
| [ | |
|
| ||||
|
| ||||
| Bi-bicyclic and bi-tricyclic compounds | ||||
| Denthyrsin | [3-(5′,6′-Dimethoxybenzofuran-2′-yl)-6,7-dimethoxy-2H-chromen-2-one |
| [ | |
| Denthyrsinol | (4,5′-Dimethoxy-[1,1′]biphenanthrenyl-2,5,4′,7-tetraol |
| [ | |
| Denthyrsinone | (7,4′,7′-Trihydroxy-2,2′,8′-trimethoxy-[5,1′]biphenanthrenyl-1,4-dione) |
| [ | |
| Denthyrsinin | 1,5,7-Trimethoxyphenanthrene-2,6-diol |
| [ | |
| Scoparone | — |
| [ | |
| b-Sitosterol | — |
| [ | |
| Daucosterol | — |
| [ | |
Polysaccharides DDP1-1, DDP2-1, and DDP3-1 isolated from D. denneanum and DNP1-1 DNP2-1, DNP3-1, and DNP4-2 isolated from D. nobile.
| ABTS radicals | Hydroxyl radicals | DPPH radicals | |
|---|---|---|---|
|
| |||
| DDP1-1 | (LW) | (LW) | (LW) |
| DDP2-1 | (LW) | (HH) | (HH) |
| DDP3-1 | (LW) | (LW) | (LW) |
|
| |||
| DNP1-1 | (LW) | (LW) | (LW) |
| DNP2-1 | (LW) | (LW) | (LW) |
| DNP3-1 | (LW) | (LW) | (LW) |
| DNP4-2 | (HH) | (HH) | (HH) |
∗Notes: Low (LW); High (HH).
Up the table: the antioxidant effect of DNP4-2 on ABTS, hydroxyl, and DPPH free radicals, suggesting the levels of DNP4-2 higher than DNP1-1, DNP2-1, and DNP3-1; however, the antioxidant effects of DDP2-1 on hydroxyl and DPPH free radicals were higher than ABTS free radicals. Moreover, the DDP1-1 and DDP 3-1 on inhibitory effect were low than other compounds. We believe that the focus on antioxidant potential of DNP4-2 and DDP2-1 structures in near future.
Assessment of the ABTS, hydroxyl, and DPPH scavenging abilities of DNP and compounds DNP4-2, DNP2-1, DNP3-1, and DNP1-1 derived from DNP.
| DNP, DNP4-2, DNP2-1, DNP3-1, and DNP1-1 | ||||
|
| ||||
| 0.5 mg for DPPH scavenging (%) | 1 mg for DPPH scavenging (%) | |||
| Type | Scavenging (%) | Type | Scavenging (%) | |
|
| ||||
| DNP | 20 | DNP | 20–30 | |
| DNP4-2 | 20–30 | DNP4-2 | 30–40 | |
| DNP2-1 | 5–10 | DNP2-1 | 10–20 | |
| DNP3-1 | About 5 | DNP3-1 | <5 | |
| DNP1-1 | <5 | DNP1-1 | About 5 | |
|
| ||||
| 0.5 mg for ABTS scavenging (%) | 1 mg for ABTS scavenging (%) | |||
| Type | Scavenging (%) | Type | Scavenging (%) | |
|
| ||||
| DNP | 30–40 | DNP | <60 | |
| DNP4-2 | About 40 | DNP4-2 | >60 | |
| DNP2-1 | <20 | DNP2-1 | About 40 | |
| DNP3-1 | ≥20 | DNP3-1 | 30–40 | |
| DNP1-1 | 10 | DNP1-1 | 30 | |
|
| ||||
| 0.5 mg for hydroxyl scavenging (%) | 1 mg for hydroxyl scavenging (%) | |||
| Type | Scavenging (%) | Type | Scavenging (%) | |
|
| ||||
| DNP | 30–40 | DNP | 35–40 | |
| DNP4-2 | 20–30 | DNP4-2 | 30–35 | |
| DNP2-1 | 10 | DNP2-1 | 10–15 | |
| DNP3-1 | 5–10 | DNP3-1 | 10 | |
| DNP1-1 | 0 | DNP1-1 | 5 | |
|
| ||||
| Based on data for DNP, DNP4-2, DNP2-1, DNP3-1, and DNP1-1 scavenging (%) | ||||
|
| ||||
| DPPH scavenging % (0.5 mg content): DNP4-2 > DNP > DNP2-1 > DNP3-1 > DNP1-1 | ||||
| DPPH scavenging % (1 mg content): DNP4-2 > DNP > DNP2-1 > DNP1-1 > DNP3-1 | ||||
|
| ||||
| ABTS scavenging % (0.5 mg content): DNP4-2 > DNP > DNP3-1 > DNP2-1 > DNP1-1 | ||||
| ABTS scavenging % (1 mg content): DNP4-2 > DNP > DNP2-1 > DNP3-1 > DNP1-1 | ||||
|
| ||||
| Hydroyl scavenging % (0.5 mg content): DNP > DNP4-2 > DNP2-1 > DNP3-1 > DNP1-1 | ||||
| Hydroyl scavenging % (1 mg content): DNP > DNP4-2 > DNP2-1 > DNP3-1 > DNP1-1 | ||||
Up the table: it is shown that DPPH and ABTS free radical scavenging (%) of DNP4-2 are better than other compounds; however, the hydroxyl free radical scavenging (%) of DNP is better than other compounds.
Comparison of the DPPH, hydroxyl, and ABTS free radical scavenging abilities of polysaccharides from D. huoshanense, D. chrysotoxum, and D. fimbriatum species.
|
| Chemical compounds | DPPH concentration (mg/mL) | |||
| 0.5% | 1% | 2% | 3% | ||
|
| |||||
|
| Polysaccharides (scavenging effects %) | 45–50 | AB 80 | 90–95 | — |
|
| Polysaccharides (scavenging effects %) | — | 10 | — | 40–50 |
|
| |||||
|
| Chemical compounds | Hydroxyl concentration (mg/mL) | |||
| 0.5% | 1% | 2% | 3% | ||
|
| |||||
|
| Polysaccharides (scavenging effects %) | 50 | 60–65 | 80 | — |
|
| Polysaccharides (scavenging effects %) | — | 55–60 | — | 70–75 |
|
| |||||
|
| Chemical compounds | ABTS concentration (mg/mL) | |||
| 0.5% | 1% | 2% | 3% | ||
|
| |||||
|
| Polysaccharides (scavenging effects %) | AB 10 | AB 20 | AB 25 | — |
|
| Polysaccharides (scavenging effects %) | — | AB 70 | — | AB 90 |
∗Notes: —: no tests and about: AB.
The scavenging hydroxyl free radicals abilities of polysaccharides from D. huoshanense and D. chrysotoxum are stronger than D. fimbriatum, and the scavenging ABTS free radicals abilities of polysaccharides from D. fimbriatum are stronger than D. huoshanense and D. chrysotoxum polysaccharides. Results showed that polysaccharides (scavenging DPPH effects %) from D. huoshanense and D. chrysotoxum are higher than hydroxyl and ABTS. And polysaccharides (scavenging ABTS effects %) from D. fimbriatum are higher than DPPH and hydroxyl free radicals.
Inhibition of compounds from D. loddigesii and D. nobile species on NO and DPPH formation.
| Species | Chemical constituent | NO | DPPH |
|---|---|---|---|
|
| Phenanthrenes (1a) | 2.6 | 26.1 |
| Phenanthrenes (2a) | 6.4 | 59.8 | |
| Phenanthrenes (3a) | 5.3 | 12 | |
| Phenanthrenes (4a) | 10.9 | — | |
| Dihydrophenanthrenes (5a) | 4.6 | 62.2 | |
| Dihydrophenanthrenes (6a) | 29.1 | — | |
| Dihydrophenanthrenes (7a) | 29.2 | — | |
| Loddigesiinols A | 2.6 | — | |
| Loddigesiinols B | 10.9 | — | |
| Loddigesiinols C | — | 23.7 | |
| Loddigesiinols D | 69.7 | — | |
|
| |||
|
| Nobilin D (1) | 15.3 | — |
| Nobilin E (2) | 19.2 | — | |
| Nobilone F (3) | 38.1 | — | |
| Phenanthrenes and bibenzyls related-composition | |||
| ROR1 = R2 = OCH3 R3 = OH R4 = H (4) | — | — | |
| ROR1 = R2 = R3 = OCH3 R4 = H (5) | 48.2 | — | |
| ROR1 = R2 = OH R3 = R4 = H (6) | — | — | |
| ROR1 = R3 = OCH3 R2 = OH R4 = H (7) | — | — | |
| ROR1 = OCH3 R2 = R3 = OH R4 = H (8) | 36.8 | — | |
| ROR1 = R3 = OH R2 = R4 = H (9) | 32.9 | — | |
| ROR1 = R3 = OH R2 = H R4 = OCH3 (10) | 13.4 | — | |
∗Notes: —: no tests; RO: relation composition.
Inhibitory effects of different compounds from D. loddigesii and D. nobile species on NO production. Result shown in Table 5, ranked from high to low as follows: loddigesiinol D > R1 = R2 = R3 = OCH3 R4 = H (5) > nobilone F (3) > R1 = OCH3 R2 = R3 = OH R4 = H (8) > R1 = R3 = OH R2 = R4 = H (9) > dihydrophenanthrenes (7a) > dihydrophenanthrenes (6a) > nobilin E (2) > nobilin D (1) > R1 = R3 = OH R2 = H R4 = OCH3 (10) > phenanthrenes (4a) = loddigesiinols B > phenanthrenes (2a) > phenanthrenes (3a) > dihydrophenanthrenes (5a) > phenanthrenes (1a) > loddigesiinols A, and all of the compounds inhibit DPPH prodruction (from high to low): dihydrophenanthrenes (5a) > phenanthrenes (2a) > phenanthrenes (1a) > loddigesiinol C > phenanthrenes (3a).
Figure 1Cytokines activated by polysaccharide and polysaccharide (HPS-IB23) from D. huoshanense. The effect of two OAc3 and three Oac2 from polysaccharide on GC-SF and GM-CSF upregulation, and also the effect of one oAc3 and two α-D-Gal from polysaccharide (HPS-IB23) on TNF-α upregulation.
The chemical compounds from D. nobile and D. moniliforme that inhibited/activated T cells and B cells.
|
| Compound/structure | Lymphocytes | |
|---|---|---|---|
| T cell | B cell | ||
|
| Dendroside D | (AD) | (AD) |
| Dendroside E | (AD) | (AD) | |
| Dendroside F | (AD) | (AD) | |
| Dendroside G | (AD) | (AD) | |
|
| |||
|
| Dendroside A | (IY) | (AD) |
| Dendroside C | (IY) | (AD) | |
| Vanilloloside | (IY) | (AD) | |
| Denbinobin | (IY) | (AD) | |
| 2,6-Dimethoxy 1,4,5,8-phenanthradiquinone | (IY) | (AD) | |
∗Notes: activation: AD; inhibition: IY.
Up the table, showed T cell and B cell activated by chemical compounds from D. nobile, and inhibit T cell and activated on B cell by chemical compounds from D. moniliforme.
The pharmacological effects of Dendrobium species.
| Species | Chemical compounds/structures | Pharmacological activities | References |
|---|---|---|---|
|
| Polysaccharides | Scavenging effect of hydroxyl, ABTS, and DPPH | [ |
| (SR) | Nobilin D, nobilin E, nobilone | Inhibitory on NO production | [ |
| (SR) | Phenanthrenes | Inhibition of LPS-induced of nitric oxide production |
[ |
| (SR) | Dendroside A, Dendronobilosides A | Immunomodulatory activity | [ |
| (SR) | Glycosides (dendrosides D–G) | Significant Stimulation of the proliferation of mouse T and/or B lymphocytes | [ |
| (SR) | Polysaccharides (DNP-W1, DNP-W2, DNP-W3, DNP-W4) | Anticancer activity | [ |
| (SR) | 4,7-Dihydroxy-2-methoxy-9,10-dihy | Anticancer activity: | [ |
| Drophenanthrene, denbinobin | (SNU-484 human gastric cancer cells) | [ | |
| (SR) | (SR) | (human lung carcinoma), SK-OV-3 | [ |
| (SR) | (SR) | (human ovary adenocarcinoma) | [ |
| (SR) | (SR) | HL-60 (human promyelocytic leukemia) cell lines | [ |
| (SR) | Bibenzyl | Inhibit on furylfuramide | [ |
| (SR) | (SR) | 4-nitroquinoline-1-oxide (4NQO) | [ |
| (SR) | (SR) | N-Methyl-N′-nitro-N-nitrosoguanidine | [ |
| (SR) | (SR) | UV irradiation | [ |
| (SR) | (SR) | 3-Amino-1,4-dimethyl-5H-pyrido[4,3b]indole (Trp-P-1) | [ |
| (SR) | (SR) | Benzo[a]pyrene (B[a]P) | [ |
| (SR) | (SR) | Aflatoxin B(1) | [ |
| (SR) | Nobilin D | Anti-inflammatory activity | [ |
| (SR) | Nobilin E | (SR) | [ |
| (SR) | Nobilone | (SR) | [ |
| (SR) | R1 = R2 = OCH3 R3 = OH R4 = H | (SR) | [ |
| (SR) | R1 = R2 = R3 = OCH3 R4 = H | (SR) | [ |
| (SR) | R1 = R3 = OCH3 R2 = OH R4 = H | (SR) | [ |
| (SR) | R1 = OCH3 R2 = R3 = OH R4 = H | (SR) | [ |
| (SR) | R1 = R3 = OH R2 = R4 = H | (SR) | [ |
| (SR) | R1 = R3 = OH R2 = H R4 = OCH3 | (SR) | [ |
|
| Phenanthrenes | Inhibition of nitric oxide (NO) | [ |
| (SR) | Loddigesiinols A–D | (SR) | [ |
| (SR) | Moscatilin, moscatin, moscatilin diacetate | Inhibited both AA and collagen-induced platelet aggregations | [ |
| (SR) | — | Inhibition of aggregation of rabbit platelets induced by arachidonic acid and collagen | [ |
|
| Polysaccharides | Inducing several cytokines, including IFN-c, IL-10, IL-6, and IL-1 | [ |
| (SR) | (SR) | Immunostimulating activity | [ |
| (SR) | (SR) | Increase of TNF- | [ |
| (SR) | (SR) | Inducing several cytokines, including hematopoietic growth factors GM-CSF and GCSF | [ |
|
| Polysaccharides | Scavenging effect of hydroxyl, ABTS, and DPPH | [ |
|
| Polysaccharides | Scavenging effect of hydroxyl, ABTS, DPPH | [ |
|
| Bibenzyl | Antioxidant activity | [ |
|
| — | Immunomodulatory activity | [ |
|
| — | Inhibition of | [ |
|
| Moscatilin, homoeriodictyol, scoparone, scopoletin, gigantol | Antiplatelet aggregation activity | [ |
|
| Erianin | Anticancer activity: hepatoma Bel7402 melanoma A375 and HL-60 cells | [ |
|
| Dendrochrysanene | TNF- | [ |
|
|
| Inhibition of | [ |
|
| Pyrenophorol derivatives | Inhibition of | [ |
∗Notes: —: no tests; SR: similar.